Helping retinal cells survive stress to protect sight
Transcriptional control of stress-induced resistance to retinal degeneration
Researchers are finding the genes that help retinal cells resist stress so people with inherited or age-related retinal degeneration might keep more vision.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11184350 on NIH RePORTER |
What this research studies
The team is studying how a protein called STAT3 turns on protective genes in retinal support cells (Müller cells) and light-sensing rod cells. They'll analyze individual retinal cells using single-cell RNA sequencing and map where STAT3 binds DNA with cell-specific ChIP-seq. By combining these datasets they aim to identify the full set of genes and networks that boost cell survival. That information could point to new, gene-independent ways to protect photoreceptors across many forms of retinal degeneration.
Who could benefit from this research
Good fit: People with inherited retinal degenerations or age-related macular degeneration would be the most relevant patients for this work or future treatments.
Not a fit: People whose vision loss is due to optic nerve disease or who have already lost most photoreceptors are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, this work could reveal targets for treatments that protect photoreceptors and slow or prevent vision loss across multiple retinal diseases.
How similar studies have performed: Previous studies have shown STAT3 activation helps retinal cells survive, but pinpointing the exact genes and networks it controls is a new and untested step.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Ash, John D — University of Pittsburgh at Pittsburgh
- Study coordinator: Ash, John D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.